Chalkias, Spyridon <br/><br/>
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis.  [electronic resource] 

 -  Annals of neurology  Jun 2014 
 - 925-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1531-8249 
<br/><br/><label>Standard No.: </label>10.1002/ana.24148  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>DNA, Viral--blood<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Interferon beta-1a<br/>Interferon-beta--therapeutic use<br/>Interferon-gamma--metabolism<br/>JC Virus--genetics<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis--complications<br/>Natalizumab<br/>Polyomavirus Infections--complications<br/>Retrospective Studies<br/>Statistics as Topic<br/>T-Lymphocytes--metabolism<br/>Time Factors